| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.74 |
1-year : | 2.93 |
| Resists | First : | 2.35 |
Second : | 2.5 |
| Pivot price | 2.32  |
|||
| Supports | First : | 2.09 |
Second : | 1.74 |
| MAs | MA(5) : | 2.35 |
MA(20) : | 2.32 |
| MA(100) : | 2.33 |
MA(250) : | 1.91 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 63.2 |
D(3) : | 65.8 |
| RSI | RSI(14): 46 |
|||
| 52-week | High : | 3.22 | Low : | 0.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SPRO ] has closed above bottom band by 43.4%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.39 - 2.4 | 2.4 - 2.42 |
| Low: | 2.25 - 2.26 | 2.26 - 2.27 |
| Close: | 2.27 - 2.3 | 2.3 - 2.32 |
Wed, 11 Feb 2026
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO) - Seeking Alpha
Thu, 05 Feb 2026
Spero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Below 200 Day Moving Average - What's Next? - MarketBeat
Thu, 05 Feb 2026
Insider Sale: Chief Operating Officer of $SPRO Sells 18,891 Shares - Quiver Quantitative
Thu, 18 Dec 2025
Spro Coffee Lab to open fourth San Francisco location in former Starbucks space - The Business Journals
Mon, 15 Dec 2025
Is Spero Therapeutics (NASDAQ:SPRO) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Wed, 10 Dec 2025
NTT Data Signs Agreement to Acquire Brazilian Company SPRO - E3-Magazin
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 56 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 22.9 (%) |
| Held by Institutions | 16.3 (%) |
| Shares Short | 1,040 (K) |
| Shares Short P.Month | 1,060 (K) |
| EPS | -0.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.46 |
| Profit Margin | -108.2 % |
| Operating Margin | -134.7 % |
| Return on Assets (ttm) | -29.8 % |
| Return on Equity (ttm) | -95.4 % |
| Qtrly Rev. Growth | -59.6 % |
| Gross Profit (p.s.) | -0.38 |
| Sales Per Share | 0.71 |
| EBITDA (p.s.) | -0.81 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -28 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -2.92 |
| PEG Ratio | 0 |
| Price to Book value | 4.89 |
| Price to Sales | 3.19 |
| Price to Cash Flow | -4.69 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|